Clinical Trial Update: Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial of iodine-131–labeled monoclonal antibody BC8 used before autologous stem cell transplant in relapsed or refractory Hodgkin lymphoma or non-Hodgki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• iodine-131 monoclonal antibody BC8 (iodine-131 labeled monoclonal antibody BC8)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma | Phase 1 | Status: TERMINATED | Results posted: 2017-10-12